The Centers for Disease Control and Prevention (CDC) awarded a $39.9 million firm fixed price definitive contract to Aegis Sciences Corporation for COVID-19 genome sequencing services. As the prime contractor, Aegis Sciences Corporation will perform the sequencing work out of its Nashville, Tennessee laboratory. The one year contract is intended to support the CDC's ongoing efforts to track genetic variations of the SARS-CoV-2 virus through genomic surveillance. No subcontractors or set aside...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a firm-fixed-price delivery order to Aegis Sciences Corporation, a for-profit organization, to provide Test Surge and Data Sharing services. This order was placed under a multiple-award indefinite-delivery, indefinite-quantity (IDIQ) contract with a total ceiling value of $2,427,648.50 and a period of performance through September 26, 2029. Aegis, operating out of its laboratory in Nashville, Tennessee, will perform COVID-19...
This firm fixed price delivery order was awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Aegis Sciences Corporation, a for-profit organization, to provide genotyping services for tracking viral variants. The order, valued at $17,771,325.00, is a task order under an existing indefinite delivery contract between NHLBI and Aegis potentially worth $47.97 million to perform viral variant genotyping work. The work will be conducted at Aegis' facility in...
The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $19,502 purchase order to Illumina, Inc. for ISEQ 100NGS kits. The firm fixed price contract has a period of performance of one day, September 6, 2023. The place of performance will be Illumina's location in Atlanta, Georgia. The CDC is likely procuring the next generation sequencing kits to support genomic surveillance efforts within its broader infectious disease programs. No...
This is a delivery order awarded by the Centers for Disease Control and Prevention (CDC) to Aegis Sciences Corporation, a forensic toxicology and healthcare laboratory company, for a Test Surge and Data Sharing multiple-award indefinite-delivery, indefinite-quantity (IDIQ) contract. The delivery order, valued at $610,000.00, will task Aegis to provide science-driven drug testing and consulting services, including COVID-19 testing, genomic sequencing, and variant tracking out of its Nashville,...
The Centers for Disease Control and Prevention (CDC) awarded a $716,320 purchase order to Theiagen Consulting LLC, doing business as Theiagen Genomics, for TERRA SUPPORT under its major program code for Communicable Disease. Theiagen Genomics will provide genomics support services from its location in Highlands Ranch, Colorado to the CDC in Pittsburgh, Pennsylvania over the one-year period beginning September 8, 2021 through August 14, 2022. The contract utilizes firm fixed pricing for the...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $2.5 million definitive contract to the Scripps Research Institute for genomic sequencing of SARS-CoV-2 to investigate local and cross-border emergence and spread. This contract was awarded under the Centers for Disease Control COVID-19 Broad Agency Announcement, which sought white papers related to developing strategies for protecting communities from COVID-19, including examining the virus's...
Agena Bioscience, Inc. has been awarded a firm fixed price purchase order valued at twenty-two thousand five hundred fifty-five dollars ($22,555) by the Centers for Disease Control and Prevention (CDC) located in Pittsburgh, Pennsylvania. The contract is for the delivery of Agena Bioscience IPLEX Pro Genotyping Kits to the CDC facility in San Diego, California, with performance taking place between September 7-15, 2023. No subcontractors or set aside designations were indicated. The genotyping...
The Centers for Disease Control and Prevention awarded a $3.975 million firm fixed price definitive contract to Illumina, Inc. of San Diego, California. The contract is for SARS-COV-2 SPHERES Baseline Genomic Sequencing to support the Department of Health and Human Services and CDC's efforts responding to the Coronavirus Disease 2019 (COVID-19) pandemic. Under this contract, Illumina will provide genomic sequencing and data analysis services to establish a baseline of SARS-CoV-2 virus genomes...
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $19,270 purchase order to Revvity Health Sciences, Inc., a subsidiary of Revvity Inc. Medical Imaging, LLC, for a BIOQULE next-generation sequencing system. The firm fixed price contract runs from July 2, 2023 through July 31, 2023 and will be performed in Shelton, Connecticut. No subcontractors or set aside designations were identified. The sequencing technology will support CDC's...